Insights into the patient’s health status through RNA and AI
RNA is central processes in the human body. It provides insight into which genes are being expressed and what biological processes are active in our body. Exheus aims to harness this underutilized information through something as simple as a blood test. The investigation into a person’s health status has become more popular in recent years in the private care and through direct-to-consumer tests. Exheus wants to take the next step to the public market and give healthcare professionals the opportunity to utilize this information with their new innovation the Exheus Gold. An interesting fact about Exheus, our new partner is the winner of the Healthy Longevity Catalyst Awards 2022.
How doe the Exheus Gold work?
Exheus developed a test which analysis the activation of genes through RNA analysis and AI. The company already offers two tests each focusing on different aspects of a personal health, nutrition, or sports performance. Their new test, the Exheus Gold, is exclusive for healthcare professionals to gain more insight into active process of proteins in the body. It measures more than 320 biomarkers of mRNA. The report contains personalized recommendations and the results can be customized to the needs of the healthcare professional. The report provides information about your metabolism, the state of your body and aging and lastly, inflammations and infections. The Exheus Gold can be used in multiple situations. For example, it enables personal lifestyle advice to increase the patient’s health or provides an indication of the origin of unexplained symptoms.
How does the Exheus Gold impact patients’ health?
The new innovation helps with healthy aging and an improving patient’s health conditions to live a better life. It can be used for different patient groups such as diabetics, rheumatism, obesity, sport athletics and many more. Currently, a patient’s health condition is measured via different health monitoring tools, such as blood tests, microbiome tests, DNA test and glucose sensors. However, Exheus offers an integral health monitoring tool that can be performed with a only a small blood sample.
The story behind the Exheus Gold
Exheus is a Spin-off of the Sant Pau Hospital Research Institute, the Polytechnic University of Catalonia (UPC) and the Mobile World Capital. The company was founded in 2020 and quickly entered the Spanish market. Recently, Exheus was announced as one of the winners in the Healthy Longevity Global Competition 2022.
Interesting stories from Exheus
Pol Cervera, COO and Co-Founder of Exheus, talked about some of their success stories: “To date, our researchers have carried out different studies that have been published in prestigious journals such as Science. Additionally, we have collaborated in observational clinical studies with prestigious European institutions in the field of sport and chronic diseases, mainly those associated with overweight, obesity and other comorbidities. We are also currently working in the field of Inflamaging (inflammation caused by aging) collaborating with more than 10 associated Spanish medical centers. On the other hand, thanks to our test we have been able to detect early low-grade chronic inflammation in many of our clients and 8/10 have improved adherence to treatments and to the guidelines recommended by specialists.”
Valuable tips from Exheus about innovating healthcare that every entrepreneur could learn from
“Never give up (unless you run out of cash).” as said by the entrepreneurs at Exheus, “A great CEO once gave me this advice which I enthusiastically share. Life in entrepreneurship is an emotional roller coaster and every day obstacles appear that will make you give up and abandon the game. It is about persisting, reflecting and seeking solutions to all those challenges that appear along the way.”
Leave your email or contact us below